The DOI matches its Crossref record.
The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Abstract
THE PURPOSE of the "Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" (JNC VI) is to provide guidance for primary care clinicians. The committee recognizes that the responsible clinician's judgment of the individual patient's needs remains paramount. Therefore, this national guideline should serve as a tool to be adapted and implemented in local and individual situations. Using evidence-based medicine and consensus, the report updates contemporary approaches to hypertension control. Among the issues covered are the important need for prevention of high blood pressure by improving lifestyles, the cost of health care, the use of self-measurement of blood pressure, the role of managed care in the treatment of high blood pressure, the introduction of new combination antihypertensive medications and angiotensin II receptor blockers, and strategies for improving adherence to treatment. The JNC VI report places more emphasis than earlier reports on absolute
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, blood pressure classification differed between the studies, the former using an arbitrary classification and the latter using the JNC-VI classification (21).”
From Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive (2001) · cites this paper as [21]
Citations
Cited by
Sorted by citations
Items 901–1,000 of 1,073
Agewall, S., Fagerberg, B., Berglund, G., Schmidt, C. B., Wendelhag, I., Wikstrand, J., & FOR THE RISK FACTOR INTERVENTION STUDY GROUP, S. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00818.x · Cited by 63
Development and clinical outcomes of pharmacist-managed diabetes care clinics
Morello, C. M., Zadvorny, E. B., Cording, M. A., Suemoto, R. T., Skog, J., & Harari, A. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050430 · Cited by 63
Kloner, R. A., Weinberger, M. H., Pool, J. L., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01491-0 · Cited by 63
Aronow, W., Ahn, C., & Gutstein, H. (2002) · The journals of gerontology. Series A, Biological sciences and medical sciences · doi:10.1093/gerona/57.11.m747 · Cited by 70
How Pharmacists Can Assist Physicians With Controlling Blood Pressure
Carter, B. L., Zillich, A. J., & Elliott, W. J. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.01460.x · Cited by 63
Nondrug interventions in hypertension prevention and control
Labarthe, D. R., & Ayala, C. (2002) · Cardiology Clinics · doi:10.1016/s0733-8651(01)00003-0 · Cited by 63
Kaminski, G., Makowski, K., Michałkiewicz, D., Kowal, J., Ruchala, M., Szczepanek, E., & Gielerak, G. (2012) · Thyroid · doi:10.1089/thy.2010.0333 · Cited by 61
Vassilatou (2014) · doi:10.1530/eje-13-0848 · Cited by 61
Medically supervised water-only fasting in the treatment of borderline hypertension
Goldhamer, A. C., Lisle, D. J., Sultana, P., Anderson, S. V., Parpia, B., Hughes, B., & Campbell, T. C. (2002) · The Journal of Alternative and Complementary Medicine · doi:10.1089/107555302320825165 · Cited by 62
Cardiovascular Risk Assessment in Hypertensive Patients
Wang, M. C., & Lloyd‐Jones, D. M. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab021 · Cited by 69
Understanding Uncontrolled Hypertension: Is It the Patient or the Provider?
Rose, A. J., Berlowitz, D. R., Orner, M. B., & Kressin, N. R. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.07332.x · Cited by 62
Yang, T., Chu, C., Bai, C., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.006 · Cited by 62
Obesity Duration Is Associated to Pulmonary Function Impairment in Obese Subjects
Santamaria, F., Montella, S., Greco, L., Valerio, G., Franzese, A., Maniscalco, M., Fiorentino, G., Peroni, D. G., Pietrobelli, A., Stefano, S. D., et al. (2011) · Obesity · doi:10.1038/oby.2011.1 · Cited by 62
Palomo, I. F., Torres, G. I., Alarcón, M. A., et al. (2006) · Revista Española de Cardiología · doi:10.1157/13095778 · Cited by 62
Assessment for Chronic Kidney Disease Service in High-Risk Patients at Community Health Clinics
Patel, H. R., Pruchnicki, M. C., & Hall, L. E. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e269 · Cited by 62
Gubler, T., & Pierce, L. (2014) · Psychology Science · doi:10.1177/0956797614540467 · Cited by 55
Aronow, W. S., Ahn, C., & Gutstein, H. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.5.m333 · Cited by 62
Hypertension‐Related Morbidity and Mortality in African Americans—Why We Need to Do Better
Ferdinand, K. C., & Sounders, E. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05295.x · Cited by 64
Sirak, T. E., Jelić, S., & Jemtel, T. H. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.063 · Cited by 62
Rodríguez‐Saldaña, J., Morley, J. E., Reynoso, M. T. M., Medina, C. A., Salazar, P., de la Cruz, E., & Torres, A. L. N. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50016.x · Cited by 62
Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension
Asmar, R. G., Gosse, P., Topouchian, J. A., N'tela, G., Dudley, A., & Shepherd, G. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2002.038 · Cited by 62
The Importance of Managing Hypertension and Dyslipidemia to Decrease Cardiovascular Disease
Kostis, J. B. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6032-4 · Cited by 61
Cox, K. L., Burke, V., Beilin, L. J., Grove, B., BLANKSBY, B. A., & Puddey, I. B. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000200514.25571.20 · Cited by 61
Low Serum Magnesium Levels and Foot Ulcers in Subjects with Type 2 Diabetes
Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00298-3 · Cited by 61
Preston, R. A., Harvey, P., Herfert, O., Dykstra, G., Jukema, J. W., Sun, F., & Gillen, D. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007307879 · Cited by 60
Ozkor, M. A., Rahman, A. M., Murrow, J. R., Kavtaradze, N., Lin, J., Manatunga, A. K., Hayek, S. S., & Quyyumi, A. A. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.303136 · Cited by 61
Mittawae, B., El-Nashaar, A., Fouda, A., Magdy, M., & Shamloul, R. M. (2006) · Urology · doi:10.1016/j.urology.2005.09.040 · Cited by 62
Genetic Effect on Blood Pressure Is Modulated by Age
Shi, G., Gu, C. C., Kraja, A. T., Arnett, D. K., Myers, R. H., Pankow, J. S., Hunt, S. C., & Rao, D. C. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.120071 · Cited by 62
Bress, A. P., Colantonio, L. D., Cooper, R., Kramer, H., Booth, J. N., Odden, M. C., Bibbins-Domingo, K. B., Shimbo, D., Whelton, P. K., Levitan, E. B., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035640 · Cited by 63
Wang, Y., Lara, J., Haskell‐Ramsay, C. F., & Lodge, J. K. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02299-w · Cited by 64
McCormack, P. L., & Wagstaff, A. J. (2003) · Drugs · doi:10.2165/00003495-200363210-00008 · Cited by 61
Kurpesa, M., Trzos, E., Dróżdż, J., et al. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00031-1 · Cited by 61
García‐Criado, Á., Gilabert, R., Nicolau, C., et al. (2005) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2005.24.12.1641 · Cited by 61
Platelet-Derived Nitric Oxide and Coronary Risk Factors
Ikeda, H., Takajo, Y., Murohara, T., Ichiki, K., Adachi, H., Haramaki, N., Katoh, A., & Imaizumi, T. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.904 · Cited by 61
Trends in death from circulatory diseases in Brazil between 1979 and 1996
Mansur, A. D. P., Favarato, D., de Souza, M. D. F. M., et al. (2001) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2001000600007 · Cited by 61
Clinical Implications of Therapeutic Exercise in HIV/AIDS
Bopp, C. M., Phillips, K. D., Fulk, L. J., et al. (2003) · Journal of the Association of Nurses in AIDS Care · doi:10.1177/1055329002239192 · Cited by 60
Wetzels, G., Nelemans, P. J., Wijk, B. L. V., Broers, N. J., Schouten, J., & Prins, M. H. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2005.12.010 · Cited by 60
Ferrari, P., & trial, T. N. C. F. T. R. F. N. I. A. T. (. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.117 · Cited by 60
Clinical Management of the Obese Hypertensive Patient
Frohlich, E. D. (2002) · Cardiology in Review · doi:10.1097/00045415-200205000-00001 · Cited by 60
Flu, H. C., Tamsma, J. T., Lindeman, J. H. N., Hamming, J. F., & Lardenoye, J.-W. H. P. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.09.027 · Cited by 60
Blood Pressure Goals in Patients with CKD
Chang, A. R., Lóser, M. K., Malhotra, R., & Appel, L. J. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07440618 · Cited by 62
Zhang, H., Thijs, L., Kuznetsova, T., Fagard, R. H., Li, X., & Staessen, J. A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000242395.07473.92 · Cited by 60
Kjeldsen, S., Dahlöf, B., Devereux, R. B., Julius, S., Fairé, U. D., Fyhrquist, F., Ibsen, H., Kristianson, K. J., Lederballe‐Pedersen, O., Lindholm, L. H., et al. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00280-6 · Cited by 60
Metabolic Profile of Indapamide Sustained-Release in Patients with Hypertension
Weidmann, P. U. (2001) · Drug Safety · doi:10.2165/00002018-200124150-00006 · Cited by 60
Obesity and cardiovascular risk factors in Hong Kong Chinese
Lee, Z. S. K., Critchley, J., Ko, G. T. C., Anderson, P. J., Thomas, G. N., Young, R. P., Chan, T. Y. K., Cockram, C. S., Tomlinson, B., & Chan, J. C. N. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00066.x · Cited by 59
Additive Pressor Effects of Caffeine and Stress in Male Medical Students at Risk for Hypertension
Shepard, J. D., Al’Absi, M., Whitsett, T. L., Passey, R. B., & Lovallo, W. R. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00217-4 · Cited by 58
Antihypertensive drug medication adherence and its affecting factors in South Korea
Park, J. H., Shin, Y., Lee, S., & Lee, S. I. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.114 · Cited by 59
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
Faria, M., Ribeiro, S., Costa, E. M., Mendonça, D. M., Teixeira, L., Rocha‐Pereira, P., Fernandes, J. C., Nascimento, H., Kohlová, M., Reis, F., et al. (2013) · Disease Markers · doi:10.1155/2013/518945 · Cited by 60
The Effect of Age on Hypertension Control and Management
Borzecki, A. M., Glickman, M. E., Kader, B., & Berlowitz, D. R. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.10.022 · Cited by 58
The Influence of β-Blockers on Delayed Memory Function in People With Cognitive Impairment
Gliebus, G. P., & Lippa, C. F. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317506295889 · Cited by 60
The Growing Gap in Hypertension Control Between Insured and Uninsured Adults
Egan, B. M., Li, J., Small, J. M., Nietert, P. J., & Sinopoli, A. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04276 · Cited by 60
Vascular events in hypertensive patients with systemic lupus erythematosus
Rahman, P., Agüero, S., Gladman, D. D., et al. (2000) · Lupus · doi:10.1191/096120300669204787 · Cited by 59
Wolf, P. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90089-7 · Cited by 60
Designer milks for the new millennium
Boland, M., MacGibbon, A. K. H., & Hill, J. P. (2001) · Livestock Production Science · doi:10.1016/s0301-6226(01)00270-6 · Cited by 61
The Impact of Co-Morbid Conditions on the SF-36: A Primary-Care-Based Study Among Hypertensives
Aydemır, Ö., Ozdemir, C., & Köroğlu, E. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.12.009 · Cited by 59
Taylor, H. A., Hughes, G. D., & Garrison, R. J. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.4.548 · Cited by 60
Predictors of Adverse Outcome Among Patients With Hypertension and Coronary Artery Disease
Pepine, C. J., Kowey, P. R., Kupfer, S., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.031 · Cited by 59
Magee, L. A. (2001) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2001.0232 · Cited by 59
Mallion, J.-M., Carretta, R., Trenkwalder, P., MARTINEZ, J.-F., Tykarski, A., Teitelbaum, I., Oddou-Stock, P., & Fagan, T. R. (2003) · Blood Pressure · doi:10.1080/08038020310000122 · Cited by 59
Lalonde, L., O'Connor, A. M. C., Drake, E. R., et al. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.9.909.36104 · Cited by 58
Guerrero‐Romero, F., Rodríguez‐Morán, M., Pérez-Fuentes, R., Sánchez-Guillén, M. C., González-Ortı́z, M., Martínez‐Abundis, E., Brito-Zurita, O. R., Madero, A., Figueroa-Núñez, B., Revilla, M., et al. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0020 · Cited by 58
A Hypertension-Associated tRNAAla Mutation Alters tRNA Metabolism and Mitochondrial Function
Jiang, P., Wang, M., Xue, L., Xiao, Y., Yu, J., Wang, H., Yao, J., Liu, H., Peng, Y., Liu, H., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00199-16 · Cited by 60
Diuretics and β-blockers: Is there a risk for dyslipidemia?
Weir, M. R., & Moser, M. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90325-9 · Cited by 58
Treatment of Systemic Hypertension in Patients With Pulmonary Disease
Dart, R. A., Gollub, S., Lazar, J., Nair, C. K., Schroeder, D. P., & Woolf, S. H. (2003) · CHEST Journal · doi:10.1378/chest.123.1.222 · Cited by 58
O’Rourke, M. F. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0022-9 · Cited by 56
Moreau, K. L., Gavin, K. M., Plum, A. E., & Seals, D. R. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000243575.09065.48 · Cited by 56
Translational Success Stories: Angiotensin Receptor 1 Antagonists in Heart Failure
Dell’Italia, L. J. (2011) · Circulation Research · doi:10.1161/circresaha.110.238550 · Cited by 55
Cannone, V., Cefalu, A. B., Noto, D., Scott, C. G., Bailey, K. R., Cavera, G., Pagano, M., Sapienza, M., Averna, M. R., & Burnett, J. C. J. (2013) · Diabetes Care · doi:10.2337/dc12-2337 · Cited by 59
Hypertension Management and Control in Primary Care: A Study of 20 Practices in 14 States
Ornstein, S. M., Nietert, P. J., & Dickerson, L. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.5.500.33359 · Cited by 57
Messerli, F. H., Bakris, G. L., Ferrera, R. D., Houston, M. C., Petrella, R. J., Flack, J. M., Sun, W. Y., Lee, E., Neutel, J. M., & on behalf of the AVALON Investigators (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05636.x · Cited by 56
Griffin, K. A., Picken, M. M., & BIDANI, A. K. (2003) · Kidney International · doi:10.1111/j.1523-1755.2004.00356.x · Cited by 57
ACE-I and ARBs in early diabetic nephropathy
Mauer, M. S., Zinman, B., GARDINER, R. J., Drummond, K. N., Suissa, S., Donnelly, S. M., Strand, T. D., Kramer, M. S., Klein, R., & Sinaiko, A. R. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2002.048 · Cited by 57
Young, T. K., Chateau, D. G., & Zhang, M. (2002) · American Journal of Human Biology · doi:10.1002/ajhb.10083 · Cited by 57
Hensrud, D. D. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.2.165 · Cited by 71
Bobbio, M., Ferrua, S., Opasich, C., Porcu, M., Lucci, D., Scherillo, M., Tavazzi, L., & Maggioni, A. P. (2003) · Journal of Cardiac Failure · doi:10.1054/jcaf.2003.31 · Cited by 56
Chi, Y., & Jaff, M. R. (2008) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21401 · Cited by 55
Fuentes, L. D. L., Soto, P. F., Cupps, B. P., Pasque, M. K., Herrero, P., Gropler, R. J., Waggoner, A. D., & Dávila‐Román, V. G. (2006) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2006.01.021 · Cited by 55
Morrison, F. J. R., Shubina, M., & Turchin, A. (2012) · Diabetes Care · doi:10.2337/dc11-1635 · Cited by 59
Amer, M., Woodward, M., & Appel, L. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006671 · Cited by 56
Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease
Shoji, T., Fukumoto, M., Kimoto, E., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00692.x · Cited by 56
Therapeutic Goal Attainment in Patients With Hypertension and Dyslipidemia
Johnson, M. L., Pietz, K., Battleman, D. S., & Beyth, R. J. (2005) · Medical Care · doi:10.1097/01.mlr.0000188982.25397.37 · Cited by 55
Rhinitis Is Associated with Increased Systolic Blood Pressure in Men: A Population-based Study
Kony, S., Zureik, M., Neukirch, C., Leynaert, B., VERVLOET, D., & Neukirch, F. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-851oc · Cited by 55
Relations of Insulin Sensitivity to Longitudinal Blood Pressure Tracking
Ärnlöv, J., Pencina, M. J., Nam, B., Meigs, J. B., Fox, C. S., Levy, D. A., D’Agostino, R. B., & Vasan, R. S. (2005) · Circulation · doi:10.1161/circulationaha.105.535039 · Cited by 55
Angiotensin-converting enzyme inhibitors.
Menard, J., & Patchett, A. (2001) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(01)56002-7 · Cited by 30
Licker, M. J., Schweizer, A., Höhn, L., Farinelli, C., & Morel, D. R. (2000) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03018973 · Cited by 56
Blood-pressure lowering for the secondary prevention of stroke
Staessen, J. A., & Wang, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06226-2 · Cited by 56
Effects of candesartan cilexetil in patients with severe systemic hypertension
Oparil, S., Levine, J. H., ZUSCHKE, C. A., Gradman, A. H., Ripley, E. B. D., Jones, D. W., Hardison, J., Cushing, D. J., Prasad, R., & Michelson, E. L. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00278-7 · Cited by 56
Patel, J., Rifai, M. A., Blaha, M. J., Budoff, M. J., Post, W. S., Polak, J. F., Bluemke, D. A., Scheuner, M. T., Kronmal, R. A., Blumenthal, R. S., et al. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003186 · Cited by 54
Tian, S., Dong, G., Wang, D., et al. (2011) · Hypertension Research · doi:10.1038/hr.2011.99 · Cited by 55
Higher Heart Rate Predicts the Risk of Developing Hypertension in a Normotensive Screened Cohort
Inoue, T., Iseki, K., Iseki, C., Kinjo, K., Ohya, Y., & Takishita, S. (2007) · Circulation Journal · doi:10.1253/circj.71.1755 · Cited by 55
Improvement of metabolic syndrome markers through altitude specific hiking vacations
Greie, S., Humpeler, E., Gunga, H., Koralewski, E., Klingler, A., Mittermayr, M., Fries, D. R., Lechleitner, M., Hoertnagl, H., HOFFMANN, G. E., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344138 · Cited by 55
Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome
Christ, M., Iannello, C., Iannello, P. G., & Grimm, W. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.01.034 · Cited by 54
Misperceptions about β-blockers and diuretics
Ubel, P. A., Jepson, C., & Asch, D. A. (2003) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2003.20414.x · Cited by 55
Palm, F., Henschke, N., Wolf, J., Zimmer, K., Safer, A., Schröder, R. J., Inselmann, G., Brenke, C., Becher, H., & Grau, A. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7013-0 · Cited by 55
Epidemiology, Diagnosis, and Management of Cardiac Disease in Chronic Renal Disease
Sarnak, M. J., & Levey, A. S. (2000) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1018718727634 · Cited by 54
Predictors of insulin sensitivity in Type 2 diabetes mellitus
Bonora, E., Targher, G., Alberiche, M., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Poli, M., Zenari, L., Raffaelli, A., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00764.x · Cited by 54
Documento de consenso: obesidad y riesgo cardiovascular
Bartrina, J. A., Foz, M., Moreno, B., Bartrina, J. A., Gil, B., Jover, E., Millán(coordinador), J., Mantilla, T., Monereo, S., & Moreno, B. (2003) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(03)78933-5 · Cited by 54
III Consenso Brasileiro de Hipertensão Arterial
Kohlmann, O., Guimarães, A. C., de Carvalho, M. H. C., Chaves, H., Machado, C. A., Praxedes, J. N., Santello, J. L., Nobre, F. D., & Mion, D. (1999) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27301999000400004 · Cited by 55
Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients
Griffith, T. F., Chua, B. S. Y., Allen, A. S., Klassen, P., Reddan, D. N., & Szczech, L. A. M. (2003) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.08.028 · Cited by 55
The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design
The DIRECT Programme Study Group, & Chaturvedi, N. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2002.047 · Cited by 55
Metadata
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1997-11-24
- Volume
- 157
- Issue
- 21
- Pages
- 2413
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W3022929210
- Cited by
- 3,777
- References
- 0
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 18 · 2023: 26 · 2022: 21 · 2021: 28 · 2020: 27 · 2019: 25 · 2018: 49 · 2017: 51 · 2016: 39 · 2015: 49 · 2014: 68 · 2013: 60 · 2012: 78
- FWCI
- 158.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- hypertension, JNC VI guidelines, blood pressure control, hypertension prevention, lifestyle modification, self-measured blood pressure, managed care, combination antihypertensive drugs, angiotensin receptor blockers, medication adherence, health care costs, primary care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
